University of South Florida

Kimberly-Clark Worldwide, Inc.

Los Alamos National Security, LLC

Luis Humberto Garcia-Rubio

German Leparc

Robert L Potter

Sharyn Orton

Yvette Mattley

Christina Bacon

Manuel Bayona

Michael D Ward

Dennis Stein Everhart

Jack Nelson Lindon

Peter C Stark

John M Dunbar

Willard Harris

Francisco Lanza

Paul J Sacoto

Smita Narayanan

Andres Cardenas

Edward P Cutolo

Alfredo Peguero

Catalina E Alupoaei

Jeffrey V Wheat

Eduardo Zurek

Catalina Elena Alupoaei

There is provided a method and device for remote sampling, preparation and optical interrogation of a sample using light scattering and light absorption methods. The portable device is a filtration-based device that removes interfering background particle material from the sample matrix by segregating or filtering the chosen analyte from the sample solution or matrix while allowing the interfering background particles to be pumped out of the device. The segregated analyte is then suspended in a diluent for analysis. The device is capable of calculating an initial concentration of the analyte, as well as diluting the analyte such that reliable optical measurements can be made. Suitable analytes include cells, microorganisms, bioparticles, pathogens and diseases. Sample matrixes include biological fluids such as blood and urine, as well as environmental samples including waste water.

Portable sample preparation and analysis system for micron and sub-micron particle characterization using light scattering and absorption spectroscopy

The system and method of the present invention relate to characterizing lipoproteins in a sample. The system includes a light source that delivers electromagnetic energy in a predetermined range of wavelengths to the sample and a sensor that senses an intensity spectrum which emerges from the sample when the sample is illuminated by the light source. A processor determines a chemical composition of the sample to determine the presence of lipoprotein particles. The processor then characterizes lipoproteins that are within in the sample by deconvoluting the intensity spectrum into a scattering spectrum and absorption spectrum. The method includes illuminating the sample with electromagnetic energy having a predetermined range of wavelengths and sensing the electromagnetic energy that emerges from the sample. The method further includes transducing the sensed electromagnetic energy which emerges from the sample into an intensity spectrum that determines the types of lipoproteins that are within the sample.

Optical method and system to determine distribution of lipid particles in a sample

A method and apparatus for characterizing the type of a blood sample and a variety of blood components are provided wherein a transmission spectrum of the sample is collected over a predetermined wavelength range. For blood typing, this spectrum is then compared with a set of control spectra collected from control blood samples having known blood types, from which the type of the blood sample can be determined. Further methods and apparatus are provided for determining the viability of and for cross matching a platelet unit Additional method and apparatus permit analysis of the sample for the presence of a contaminant, Particles can also be counted in the sample, even when present in low concentrations, including white blood cell.

Spectrophotometric method and apparatus for the cross-matching of platelets

The present invention provides a method and apparatus for the detection of an infectious disease or disorder in a fluid, such as a mammalian blood sample, the detection of a specific protein in a urine sample, or the detection of a particle in a plasma. The identification of the particles of interest is enable by taking a transmission spectrum of a test sample in at least a portion of the ultraviolet, visible, near-infrared portion of the spectrum and comparing the spectrum with a standard sample spectrum. From the comparison it is then determined whether the fluid from the test sample contains an particle of interest, and an identity of the particle of interest is determined. Spectroscopic and multiwavelength turbidimetry techniques provide a rapid, inexpensive, and convenient means for diagnosis. The comparison and determination steps may be performed visually or by spectral deconvolution.

Spectrophotometric system and method for the identification and characterization of a particle in a bodily fluid

A method and apparatus for characterizing the type of a blood sample and a variety of blood components are provided wherein a transmission spectrum of the sample is collected over a predetermined wavelength range. For blood typing, this spectrum is then compared with a set of control spectra collected from control blood samples having known blood types, from which the type of the blood sample can be determined. Further methods and apparatus are provided for determining the viability of and for cross matching a platelet unit. Additional method and apparatus permit analysis of the sample for the presence of a contaminant. Particles can also be counted in the sample, even when present in low concentrations, including white blood cell.

Spectrophotometric method  for determining the viability of a sample containing platelets

An infectious disease or disorder in a fluid, such as a mammalian blood sample, is detected by taking a transmission spectrum of a test sample in at least a portion of the ultraviolet visible near-infrared and comparing the spectrum with a standard sample spectrum. From the comparison it is then determined whether the fluid from the test sample contains an infectious disease or disorder, and an identity of the infectious disease or disorder is determined. Spectroscopic and multiwavelength turbidimetry techniques provide a rapid, inexpensive, and convenient means for diagnosis. The comparison and determination steps may be performed visually or by spectral deconvolution.

A method and apparatus for characterizing the type of a blood sample are provided wherein an optical density spectrum of the sample is collected over a predetermined wavelength range. A reference optical density spectrum is collected over a predetermined wavelength range for a portion of the blood sample diluted in saline. Another portion of the blood sample is then mixed with an antibody corresponding to a known blood type (e.g., anti-A, anti-B, anti-D antibody). The optical density spectrum is then collected over a predetermined wavelength range for blood diluted with saline and each antibody in saline. The slopes are then calculated over a predetermined wavelength range for each spectrum. A numerical indicator of agglutination is then calculated by dividing the slope of each antibody-treated sample by the slope of the sample in saline. The resulting number is multiplied by 100. The agglutination index (AI) is arrived at by subtracting this number from 100 so that the magnitude of the AI is a reflection of the degree of agglutination of the sample. A high index value indicates large agglutination (i.e., strong interaction with antibody). Blood type is determined by comparing the AI to a predetermined empirical cutoff value. Typically cutoff values greater than 17 indicate type-specific interaction (type AB samples yield AI values over 17 with both anti-A and anti-B antibodies, while type O samples yield AI values less than 17 with both anti-A and anti-B antibodies).

Spectrophotometric method and apparatus for blood typing

A system and method for the automatic sampling and dilution of homogeneous particle dispersions is developed that uses a multistep parallel dilution network system for the sample and diluent and includes variable dilution capabilities. The sample and diluent are combined and allowed to mix uniformly over a predetermined conduit length. Resampling from the first dilution step and recombining with another diluent line results in a second dilution step. The number of steps determines the dilution range; the manipulation of the sample and diluent flow rates provides a variable dilution ratio at each dilution step. An exemplary embodiment reduces the concentration of a latex sample for analysis with uv-vis spectrometry. In another embodiment, the emulsion polymerization of styrene is followed in real time with turbidity measurements taken on diluted samples.

Continuous sampling and dilution system and method

A system and method are provided for the characterization of a sample containing a macromolecule in solution. A light source illuminates the sample, generally in the ultraviolet-visible wavelength range, and a plurality of sensors that are radially disposed about the sample at a plurality of observation angles simultaneously sense the light energy emerging from the sample. An intensity spectrum is calculated as a function of wavelength for each observation angle, from which is calculated a particle characteristic such as shape, conformational change, composition, and particle size distribution. Both scattering and absorption data are utilized to provide complementary information.

Multiangle, multiwavelength particle characterization system and method

A method and apparatus for determining the type of a blood sample are provided wherein a turbidity spectrum of the blood sample is collected over a predetermined wavelength range, from which is calculated an extinction spectrum. This extinction spectrum is then compared with a set of control spectra collected from control blood samples having known blood types, from which the type of the blood sample can be determined. A further method is provided for for detecting the presence of a substance in a bodily fluid sample, the substance having a size in the range of generally 0.5 to 20 .mu.m. Exemplary substances that could be of interest to detect include, but are not limited to, hemoglobin, bilirubin, red blood cell antigens, microorganisms, and viruses. This embodiment includes the additional step of deconvoluting the extinction spectrum to obtain a particle size distribution for comparison with a database of control samples.

Growing community of inventors

Temple Terrace, FL, United States of America

Luis Humberto Garcia-Rubio